Anticoagulant drug heparin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Organisms1

Diseases18

Thromboembolism Hemorrhage Thrombosis Thrombophlebitis Venous Thrombosis Antiphospholipid Syndrome Pulmonary Embolism Venous Thromboembolism Blood Coagulation Disorders Thrombophilia Atrial Fibrillation Activated Protein C Resistance Antithrombin III Deficiency Protein C Deficiency Thrombocytopenia Hematoma Protein S Deficiency Disseminated Intravascular Coagulation

Chemicals and Drugs61

Anticoagulants Warfarin Factor Xa Heparin Thrombin Platelet Aggregation Inhibitors Heparin, Low-Molecular-Weight Lupus Coagulation Inhibitor Heparin Antagonists Antithrombins Heparin Lyase Protein C Heparin Cofactor II Antithrombin III Acenocoumarol Rodenticides Phenindione 4-Hydroxycoumarins Blood Coagulation Factors Protein S Prothrombin Thrombomodulin beta-Alanine Enoxaparin Hirudins Fibrinolytic Agents Vitamin K Dermatan Sulfate Dalteparin Phenprocoumon Antibodies, Antiphospholipid Glycosaminoglycans Factor X Antibodies, Anticardiolipin Pipecolic Acids Thromboplastin Protamines Factor V Platelet Factor 4 Coagulants Dicumarol Aspirin beta 2-Glycoprotein I Heparinoids Factor Va Polysaccharides Thiophenes Antithrombin Proteins Polysaccharide-Lyases Recombinant Proteins Chondroitin Sulfates Fibrin Vitamin K Epoxide Reductases Benzimidazoles Oligosaccharides Pyridones Serine Proteinase Inhibitors Disaccharides Cardiolipins Citric Acid Sulfates

Analytical, Diagnostic and Therapeutic Techniques and Equipment11

International Normalized Ratio Partial Thromboplastin Time Prothrombin Time Blood Coagulation Tests Thrombin Time Whole Blood Coagulation Time Administration, Oral Hirudin Therapy Drug Monitoring Treatment Outcome Chromatography, Affinity

Phenomena and Processes11

Blood Coagulation Partial Thromboplastin Time Prothrombin Time Thrombin Time Whole Blood Coagulation Time Hemostasis Protein Binding Time Factors Kinetics Dose-Response Relationship, Drug Binding Sites

Information Science1

Molecular Sequence Data

Health Care2

Rodent Control Treatment Outcome

Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Anticoagulants Warfarin Factor Xa International Normalized Ratio Heparin Blood Coagulation Thrombin Platelet Aggregation Inhibitors Heparin, Low-Molecular-Weight Lupus Coagulation Inhibitor Heparin Antagonists Partial Thromboplastin Time Antithrombins Heparin Lyase Prothrombin Time Protein C Heparin Cofactor II Antithrombin III Blood Coagulation Tests Acenocoumarol Thrombin Time Rodenticides Thromboembolism Hemorrhage Phenindione 4-Hydroxycoumarins Thrombosis Blood Coagulation Factors Protein S Thrombophlebitis Prothrombin Thrombomodulin beta-Alanine Enoxaparin Venous Thrombosis Hirudins Antiphospholipid Syndrome Fibrinolytic Agents Vitamin K Pulmonary Embolism Dermatan Sulfate Dalteparin Venous Thromboembolism Phenprocoumon Antibodies, Antiphospholipid Blood Coagulation Disorders Thrombophilia Whole Blood Coagulation Time Glycosaminoglycans Factor X Administration, Oral Antibodies, Anticardiolipin Pipecolic Acids Thromboplastin Protamines Hemostasis Factor V Platelet Factor 4 Coagulants Dicumarol Aspirin beta 2-Glycoprotein I Heparinoids Factor Va Atrial Fibrillation Polysaccharides Thiophenes Activated Protein C Resistance Rodent Control Antithrombin Proteins Antithrombin III Deficiency Polysaccharide-Lyases Hirudin Therapy Recombinant Proteins Chondroitin Sulfates Protein Binding Protein C Deficiency Thrombocytopenia Fibrin Time Factors Vitamin K Epoxide Reductases Benzimidazoles Oligosaccharides Hematoma Drug Monitoring Treatment Outcome Protein S Deficiency Kinetics Pyridones Dose-Response Relationship, Drug Serine Proteinase Inhibitors Disaccharides Chromatography, Affinity Cardiolipins Citric Acid Sea Cucumbers Binding Sites Molecular Sequence Data Disseminated Intravascular Coagulation Sulfates

No FAQ available that match "anticoagulant drug heparin"